false
0001864531
0001864531
2024-12-18
2024-12-18
0001864531
us-gaap:CommonStockMember
2024-12-18
2024-12-18
0001864531
us-gaap:WarrantMember
2024-12-18
2024-12-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
December 18, 2024
VSEE
HEALTH, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-41015 |
|
86-2970927 |
(State or other jurisdiction of incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer Identification No.) |
980 N Federal Hwy #304
Boca Raton, Florida |
|
33432 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (561) 672-7068
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class |
|
Trading
Symbol |
|
Name of each exchange
on
which registered |
Common Stock, $0.0001 par value per share |
|
VSEE |
|
The Nasdaq Stock Market LLC |
Warrants,
which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share |
|
VSEEW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company x
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01. Regulation FD Disclosure.
On December 18, 2024, VSee Health, Inc. (the “Company”)
issued a press release announcing that it has been awarded a national group purchasing agreement for teleradiology services with Premier,
Inc., a leading technology-enabled healthcare improvement company. A copy of the press release is furnished as Exhibit 99.1 hereto and
incorporated herein by reference.
On December 19, 2024, the Company issued a press
release announcing the award of a teleradiology contract with one of the largest post-acute care hospital systems in the United States.
A copy of the press release is furnished as Exhibit 99.2 hereto and incorporated herein by reference.
The information included in this Item 7.01,
Exhibit 99.1, and Exhibit 99.2 of this Current Report on Form 8-K is not deemed to be “filed” for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section,
nor shall this item, Exhibit 99.1 and Exhibit 99.2 be incorporated by reference into the Company’s filings under the Securities
Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such future filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: December 23, 2024 |
VSEE HEALTH, INC. |
|
|
|
|
By: |
/s/ Imoigele Aisiku |
|
Name: |
Imoigele Aisiku |
|
Title: |
Co-Chief Executive Officer |
Exhibit 99.1
VSee Health Awarded Teleradiology Services Agreement
with Premier, Inc.
SAN JOSE, Calif. -- December 18, 2024 --VSee Health,
Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance patient care, has been
awarded a national group purchasing agreement for teleradiology services with Premier, Inc., a leading technology-enabled healthcare improvement
company. Effective September 1, 2024, the new agreement, allows Premier members, at their discretion, to take advantage of special pricing
and terms pre-negotiated by Premier for VSee Health’s teleradiology services.
“Our teleradiology services are uniquely
designed to address the complex and evolving demands of modern healthcare systems,” said Imo Aisiku, M.D., Co-CEO of VSee Health.
“As many health systems continue to face resource constraints and specialist shortages in the wake of the COVID-19 pandemic, this
agreement enables us to further expand access to our scalable, cutting-edge telehealth solutions. With teleradiology already gaining significant
traction, we are excited to extend this essential service to Premier’s expansive network, ensuring greater access to high-quality
care.”
Teleradiology services are transforming radiology
practice by enabling the remote interpretation of medical imaging, which expedites diagnostics and treatment planning. VSee Health’s
teleradiology solutions leverage high-definition video and advanced image-sharing technology to provide radiologists with seamless connectivity
to healthcare teams and patients from any location, driving improved patient outcomes and creating operational efficiencies for hospitals
and imaging centers.
The teleradiology market is a key driver within
the expanding global radiology sector, which was valued at $30.0 billion in 2023 and is projected to reach $48.5 billion by 2031, growing
at a CAGR of 6.20%. This growth reflects the increasing demand for advanced diagnostic capabilities and remote imaging solutions. The
rise of teleradiology is transforming healthcare delivery by ensuring radiology services are accessible to underserved areas, reducing
delays in diagnosis, and enabling real-time consultations. By aligning with these trends, VSee Health is strategically positioned to capture
market share and deliver value through its innovative, scalable telehealth solutions.
Premier is a leading technology-driven healthcare
improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly
evolving healthcare industry, Premier unites providers, suppliers, payers and policymakers to make healthcare better with national scale,
smarter with actionable intelligence and faster with novel technologies. With integrated data and analytics, collaboratives, supply chain
solutions, consulting and other services, Premier enables better care and outcomes at a lower cost.
About VSee
VSee Health’s AI telehealth platform is
the fastest way for enterprises to go from ideation to market go-live. Field-hardened on over 1.5M HIPAA-compliant video encounters every
month, its customizable telehealth building blocks each meet stringent government security standards and are ready to scale. VSee Health
has traveled for field deployments to over 50 countries such as Iraq, Syria, Marshall Islands and El Salvador. Its clients include NASA
Space Station, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country
of Qatar.
VSee Health also provides tailored solutions for
critical shortage areas such as critical care and teleradiology. It is committed to empowering high quality healthcare access and reducing
physician burnout and workforce shortages through its telehealth technology. Visit vseehealth.com.
Forward-Looking Statements
This press release includes “forward-looking
statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.
Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects,”
“intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,”
“seeks,” or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company’s
ability to regain compliance with Nasdaq’s listing rules within the required timeframe. These statements are based on current expectations
on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly,
including those risks set forth in the Company’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on
Form 10-Q and other documents filed with the SEC. Copies of such filings are available on the SEC’s website at www.sec.gov. The
Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments
or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
Contacts
Media:
VSee Health
Anne Chang
1-626-513-1824
media@vsee.com
Investor:
Dave Gentry
RedChip Companies
1-407-644-4256
VSEE@redchip.com
Exhibit 99.2
VSee Health Secures Teleradiology Contract with
Leading Post-Acute Care Hospital System
SAN JOSE, Calif-- December 19, 2024 --VSee Health,
Inc. (Nasdaq: VSEE), a leader in telehealth solutions, today announced the award of a teleradiology contract with one of the largest post-acute
care hospital systems in the United States. This partnership, set to launch in Q1 of 2025, marks the latest addition to VSee’s growing
roster of teleradiology customers and reinforces its position as a trusted provider of advanced imaging solutions.
The initial rollout will include three hospital
locations representing a potential $1.5 million in annual recurring revenue, with the contract structured to automatically renew annually.
Through this collaboration, VSee aims to improve diagnostic accuracy, accelerate turnaround times for imaging results, and enhance patient
outcomes through seamless, 24/7 radiology interpretations.
Highlights of VSee’s Teleradiology Solutions:
| · | Improved Diagnostic Efficiency: Real-time, remote interpretation of X-rays, MRIs, and CT scans,
reducing delays in patient diagnosis and treatment initiation. |
| · | Enhanced Flexibility for Radiologists: VSee’s technology enables radiologists to provide
expertise from any location, ensuring round-the-clock coverage without disrupting workflow. |
| · | Customizable Cloud Clinic: VSee’s platform allows integration with existing systems, facilitating
smooth consultations, second opinions, and real-time collaboration with specialists. |
“Securing this partnership reflects growing
recognition of VSee’s capabilities in delivering scalable telehealth solutions tailored to meet critical healthcare needs,”
said Dr. Imo Aisiku, Co-CEO and Chairman of VSee Health. “By offering streamlined radiology workflows and unparalleled access to
top-tier radiology expertise, we are empowering post-acute care providers to deliver faster, higher-quality care for their patients.”
VSee’s teleradiology services leverage cutting-edge
telemedicine tools to connect radiologists with healthcare providers across hospitals, nursing facilities, and mobile clinics. Through
cloud-based imaging platforms, radiologists can interpret scans, collaborate with physicians, and consult with patients in real-time,
eliminating geographic limitations and improving operational efficiency.
The U.S. teleradiology market is poised for rapid
growth, driven by rising demand for timely diagnostics and the increasing adoption of telemedicine in post-acute care settings. VSee’s
growing presence in this market underscores the company’s leadership in delivering critical solutions that modernize healthcare
delivery.
About VSee Health
VSee Health is a leading provider of telehealth
solutions, specializing in real-time virtual care, clinical review, and billing services. Its technology powers healthcare networks and
organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over
1.5M HIPAA-compliant video encounters every month, VSee Health’s highly scalable, customizable telehealth building blocks each meet
stringent security standards. VSee Health has deployed services in over 50 countries, including Iraq, Syria, Marshall Islands and El Salvador.
Its clients include NASA, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire
country of Qatar. VSee Health also provides tailored solutions for critical shortage areas such as critical care and teleradiology. VSee
Health is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth
technology. For more information, please visit www.vseehealth.com.
Forward-Looking Statements
Matters discussed in this news release that are
not statements of historical or current facts, including but not limited to those relating to VSee Health’s ability to improve healthcare
access and provider efficiencies, are “forward-looking statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance
or achievements to be materially different from historical results or from any future performance or achievements expressed or implied
by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information
on risk factors relating to VSee Health and its technology and billing services is included from time to time in the “Cautionary
Note Regarding Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of
Financial Condition and Results of Operations” sections of VSee Health’s periodic and current filings with the SEC, which
are also made available on VSee Health’s website at www.vseehealth.com. Forward-looking statements speak only as of the date they
are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of
new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance
on forward-looking statements.
Contacts
Dave Gentry, CEO
RedChip Companies, Inc.
1-407-644-4256
VSEE@redchip.com
v3.24.4
Cover
|
Dec. 18, 2024 |
Document Type |
8-K
|
Amendment Flag |
false
|
Document Period End Date |
Dec. 18, 2024
|
Entity File Number |
001-41015
|
Entity Registrant Name |
VSEE
HEALTH, INC.
|
Entity Central Index Key |
0001864531
|
Entity Tax Identification Number |
86-2970927
|
Entity Incorporation, State or Country Code |
DE
|
Entity Address, Address Line One |
980 N Federal Hwy #304
|
Entity Address, City or Town |
Boca Raton
|
Entity Address, State or Province |
FL
|
Entity Address, Postal Zip Code |
33432
|
City Area Code |
561
|
Local Phone Number |
672-7068
|
Written Communications |
false
|
Soliciting Material |
false
|
Pre-commencement Tender Offer |
false
|
Pre-commencement Issuer Tender Offer |
false
|
Entity Emerging Growth Company |
true
|
Elected Not To Use the Extended Transition Period |
false
|
Common Stock [Member] |
|
Title of 12(b) Security |
Common Stock, $0.0001 par value per share
|
Trading Symbol |
VSEE
|
Security Exchange Name |
NASDAQ
|
Warrant [Member] |
|
Title of 12(b) Security |
Warrants,
which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share
|
Trading Symbol |
VSEEW
|
Security Exchange Name |
NASDAQ
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
VSee Health (NASDAQ:VSEEW)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
VSee Health (NASDAQ:VSEEW)
Historical Stock Chart
Von Dez 2023 bis Dez 2024